SOLENO THERAPEUT. DL-001 (6XC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.108x

Based on the latest financial reports, SOLENO THERAPEUT. DL-001 (6XC) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€48.70 Million ≈ $56.94 Million USD) by net assets (€450.12 Million ≈ $526.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SOLENO THERAPEUT. DL-001 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how SOLENO THERAPEUT. DL-001's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 6XC current and long-term liabilities for a breakdown of total debt and financial obligations.

SOLENO THERAPEUT. DL-001 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SOLENO THERAPEUT. DL-001 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wenzhou Yihua Connector Co Ltd SHE:002897	-0.029x
TAV HAVALIMAN.HLDG ADR/4 F:5THA	-0.065x
Enerflex Ltd. TO:EFX	0.046x
Pandox AB (publ) ST:PNDX-B	0.016x
Ningxia Jiaze Renewables Corp SHG:601619	0.189x
Jeju Semiconductor Corp KQ:080220	0.022x
Shenzhen Overseas Chinese Town Co Ltd SHE:000069	0.045x
Energisa S.A SA:ENGI3	-0.079x

Annual Cash Flow Conversion Efficiency for SOLENO THERAPEUT. DL-001 (2021–2025)

The table below shows the annual cash flow conversion efficiency of SOLENO THERAPEUT. DL-001 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see SOLENO THERAPEUT. DL-001 (6XC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€450.12 Million ≈ $526.23 Million	€46.80 Million ≈ $54.71 Million	0.104x	+136.88%
2024-12-31	€245.11 Million ≈ $286.56 Million	€-69.10 Million ≈ $-80.78 Million	-0.282x	-78.03%
2023-12-31	€157.51 Million ≈ $184.14 Million	€-24.94 Million ≈ $-29.16 Million	-0.158x	+92.12%
2022-12-31	€10.35 Million ≈ $12.10 Million	€-20.78 Million ≈ $-24.30 Million	-2.008x	-28.67%
2021-12-31	€17.79 Million ≈ $20.80 Million	€-27.77 Million ≈ $-32.47 Million	-1.561x	--

About SOLENO THERAPEUT. DL-001

F:6XC Germany Biotechnology

Market Cap

$2.73 Billion

€2.34 Billion EUR

Market Cap Rank

#5893 Global

#896 in Germany

Share Price

€44.86

Change (1 day)

+1.70%

52-Week Range

€25.52 - €73.10

All Time High

€73.10